Last deal

$2.9M

Amount

Post-IPO Equity

Stage

25.06.2009

Date

7

all rounds

$59.9M

Total amount

General

About Company
BioMimetic Therapeutics develops products for orthopedic care that stimulate the body's natural tissue regeneration.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1999

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company's products and candidates include Augment Injectable and Augment Rotator Cuff, which treat foot and ankle fusions, wrist fracture healing, surgical treatment of rotator cuff tears, and tendon overuse injuries. Founded in 1999, BioMimetic Therapeutics is headquartered in Franklin, Tennessee and develops biologically active drug-device combination products for healing injuries and diseases to the skeleton and associated tissues.
Contacts